Hyaluronic acid (HA) skin restructurer AUTENTICA has launched in the UK, with Fox Pharma and MedFx appointed as its exclusive distributors.
Developed by Regenyal, AUTENTICA is intended for advanced skin bio-restructuring, hydration and dermal-quality improvement. Each syringe contains 64mg of ultra-pure, high-molecular-weight HA (800–1200 kDa), formulated to support hydration, firmness and tissue vitality without adding visible volume, according to the distributors.
Fox Pharma and MedFx add that the product uses Regenyal’s proprietary PHYSIOLOGIC TECH, a controlled production process designed to create a stable HA structure without chemical cross-linkers or BDDE.
The distributors explain that AUTENTICA is administered using the trademarked anti-gravity technique, which places the product in the superficial adipose layer rather than following a standard skin booster protocol. Fox Pharma and MedFx state that this approach is intended to support a natural lifting effect alongside improvements in skin quality.
Dr Hasaneen Al Janabi, founder of Dr Hass Clinic and lead UK key opinion leader, commented, “For me, AUTENTICA represents an exciting and innovative movement within aesthetics because it sits somewhere between improving skin quality and creating a subtle structural effect. It isn’t simply about adding hydration, but rather enhancing the skin in a precise way through the Anti-Gravity Technique. This allows for a much more considered approach to product placement, with the aim of supporting the skin’s natural structure and creating a subtle lifting effect.”